3 reports

  • CLINICAL TRIAL PROFILE SNAPSHOTS

## ## ## ## ## ## MyoKardia Inc ## ## ## ## ## ## Heart Metabolics Ltd ## ## ## ## ## ## Quintiles IMS Holdings Inc ## ## ## ## ## ## Physicians' Services Incorporated Foundation ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## Katak

  • Cardiovascular Disease
  • Hospital
  • World
  • Product Initiative
  • MyoKardia, Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

## ## ## ## ## ## ## ## China ## ## ## ## ## ## ## ## India ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Turkey ## ## ## ## ## ## ## ## Mexico Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are tak

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Hospital
  • MyoKardia, Inc.
  • AUG 23, 2018: NEW INSIGHTS ON DISEASE BURDEN FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS PUBLISHED IN CIRCULATION
  • FEB 01, 2017: MYOKARDIA ANNOUNCES APPOINTMENT OF JUNE LEE, M.D., AS CHIEF OPERATING OFFICER AND RADHIKA TRIPURANENI, M.D., AS VICE PRESIDENT, MEDICAL AFFAIRS

HCM-##, DCM-## AND LUS-## ARE BEING EVALUATED IN PRECLINICAL PHASE.

  • Cardiovascular Disease
  • Hospital
  • United States
  • Company Financials
  • MyoKardia, Inc.